| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 56 | 2023 | 152 | 16.360 |
Why?
|
| Airway Obstruction | 23 | 2020 | 109 | 7.740 |
Why?
|
| Lung Neoplasms | 27 | 2023 | 2262 | 3.970 |
Why?
|
| Tracheobronchomalacia | 8 | 2020 | 11 | 3.590 |
Why?
|
| Endosonography | 11 | 2022 | 96 | 3.310 |
Why?
|
| Tracheal Stenosis | 9 | 2021 | 23 | 3.230 |
Why?
|
| Pulmonary Medicine | 9 | 2023 | 46 | 3.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 13 | 2022 | 1075 | 2.410 |
Why?
|
| Stents | 12 | 2019 | 377 | 2.280 |
Why?
|
| Laryngostenosis | 4 | 2021 | 16 | 2.260 |
Why?
|
| Pleural Effusion, Malignant | 3 | 2024 | 15 | 2.250 |
Why?
|
| Bronchial Diseases | 6 | 2016 | 12 | 2.150 |
Why?
|
| Image-Guided Biopsy | 6 | 2021 | 66 | 1.960 |
Why?
|
| Pneumonectomy | 5 | 2020 | 196 | 1.660 |
Why?
|
| Laser Therapy | 7 | 2019 | 142 | 1.630 |
Why?
|
| Lung Diseases | 5 | 2019 | 263 | 1.560 |
Why?
|
| Robotic Surgical Procedures | 3 | 2022 | 267 | 1.550 |
Why?
|
| Tracheostomy | 6 | 2021 | 42 | 1.510 |
Why?
|
| Respiratory Insufficiency | 4 | 2020 | 150 | 1.400 |
Why?
|
| Problem-Based Learning | 3 | 2018 | 25 | 1.380 |
Why?
|
| Positive-Pressure Respiration | 4 | 2014 | 41 | 1.330 |
Why?
|
| Pneumothorax | 6 | 2021 | 52 | 1.320 |
Why?
|
| Humans | 92 | 2024 | 86643 | 1.270 |
Why?
|
| Ablation Techniques | 3 | 2019 | 34 | 1.240 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 4 | 2021 | 25 | 1.110 |
Why?
|
| Pleural Effusion | 2 | 2024 | 45 | 1.090 |
Why?
|
| Respiratory System | 3 | 2021 | 116 | 1.040 |
Why?
|
| Tracheal Diseases | 4 | 2009 | 13 | 1.000 |
Why?
|
| Photochemotherapy | 6 | 2023 | 97 | 0.980 |
Why?
|
| Sarcoidosis | 2 | 2023 | 71 | 0.970 |
Why?
|
| Clinical Competence | 6 | 2017 | 751 | 0.960 |
Why?
|
| Tomography, Optical Coherence | 4 | 2013 | 130 | 0.960 |
Why?
|
| Pulmonologists | 1 | 2023 | 6 | 0.950 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 30 | 0.940 |
Why?
|
| Palliative Care | 3 | 2016 | 257 | 0.920 |
Why?
|
| Asthma | 5 | 2020 | 955 | 0.900 |
Why?
|
| Trachea | 4 | 2013 | 293 | 0.830 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2020 | 247 | 0.810 |
Why?
|
| Pleurodesis | 2 | 2020 | 8 | 0.810 |
Why?
|
| Stakeholder Participation | 1 | 2021 | 19 | 0.800 |
Why?
|
| Respiration, Artificial | 4 | 2021 | 334 | 0.790 |
Why?
|
| Lymphadenopathy | 1 | 2021 | 17 | 0.780 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2021 | 2601 | 0.770 |
Why?
|
| Biopsy | 6 | 2020 | 1163 | 0.770 |
Why?
|
| Pulmonary Emphysema | 3 | 2019 | 30 | 0.760 |
Why?
|
| Muscular Diseases | 1 | 2020 | 63 | 0.750 |
Why?
|
| Bronchi | 5 | 2017 | 229 | 0.750 |
Why?
|
| Betacoronavirus | 2 | 2020 | 258 | 0.740 |
Why?
|
| Anesthesia, Intravenous | 1 | 2019 | 35 | 0.720 |
Why?
|
| Neoplasm Staging | 8 | 2022 | 1939 | 0.720 |
Why?
|
| Neuromuscular Blockade | 1 | 2019 | 26 | 0.720 |
Why?
|
| Patient Care Team | 2 | 2021 | 280 | 0.690 |
Why?
|
| Lymphoma | 1 | 2021 | 262 | 0.690 |
Why?
|
| Drainage | 1 | 2020 | 157 | 0.680 |
Why?
|
| Emphysema | 2 | 2019 | 22 | 0.680 |
Why?
|
| B7-H1 Antigen | 2 | 2017 | 250 | 0.670 |
Why?
|
| Dyspnea | 3 | 2016 | 73 | 0.650 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 316 | 0.640 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 301 | 0.640 |
Why?
|
| Cartilage Diseases | 2 | 2007 | 16 | 0.590 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 107 | 0.580 |
Why?
|
| Tracheal Neoplasms | 2 | 2013 | 8 | 0.570 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2020 | 1313 | 0.550 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 329 | 0.550 |
Why?
|
| Dilatation | 2 | 2013 | 48 | 0.540 |
Why?
|
| Lung | 7 | 2023 | 1170 | 0.540 |
Why?
|
| Military Personnel | 1 | 2017 | 85 | 0.540 |
Why?
|
| Health Personnel | 1 | 2017 | 202 | 0.530 |
Why?
|
| Thoracoscopy | 1 | 2015 | 22 | 0.520 |
Why?
|
| Prostheses and Implants | 2 | 2019 | 121 | 0.520 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 46 | 0.520 |
Why?
|
| Pleura | 1 | 2015 | 30 | 0.520 |
Why?
|
| Device Removal | 1 | 2016 | 161 | 0.510 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 125 | 0.500 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 456 | 0.490 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 45 | 0.480 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2013 | 17 | 0.480 |
Why?
|
| Retrospective Studies | 10 | 2022 | 8489 | 0.460 |
Why?
|
| Aged | 18 | 2022 | 18415 | 0.460 |
Why?
|
| Postoperative Complications | 2 | 2016 | 2207 | 0.450 |
Why?
|
| Physicians | 1 | 2021 | 673 | 0.450 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2021 | 93 | 0.440 |
Why?
|
| Silicones | 2 | 2009 | 16 | 0.440 |
Why?
|
| Constriction, Pathologic | 4 | 2021 | 213 | 0.430 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 1076 | 0.430 |
Why?
|
| Male | 25 | 2021 | 40965 | 0.430 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 160 | 0.410 |
Why?
|
| Catheters, Indwelling | 2 | 2024 | 110 | 0.410 |
Why?
|
| Pandemics | 4 | 2022 | 740 | 0.400 |
Why?
|
| Bronchoscopes | 1 | 2010 | 4 | 0.380 |
Why?
|
| Respiratory Mechanics | 2 | 2009 | 102 | 0.370 |
Why?
|
| Ultrasonography | 3 | 2019 | 695 | 0.360 |
Why?
|
| Bronchial Fistula | 1 | 2009 | 10 | 0.360 |
Why?
|
| Middle Aged | 17 | 2021 | 25028 | 0.350 |
Why?
|
| Bronchial Neoplasms | 1 | 2009 | 9 | 0.350 |
Why?
|
| Respiratory Function Tests | 3 | 2021 | 136 | 0.340 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2009 | 44 | 0.340 |
Why?
|
| Critical Care | 2 | 2011 | 370 | 0.330 |
Why?
|
| Female | 20 | 2021 | 44532 | 0.330 |
Why?
|
| Ultrasonography, Interventional | 2 | 2020 | 121 | 0.330 |
Why?
|
| Argon Plasma Coagulation | 2 | 2019 | 6 | 0.320 |
Why?
|
| Lymphatic Metastasis | 3 | 2021 | 486 | 0.320 |
Why?
|
| Electrocoagulation | 2 | 2019 | 22 | 0.320 |
Why?
|
| Specimen Handling | 2 | 2020 | 98 | 0.300 |
Why?
|
| Lymph Nodes | 3 | 2021 | 533 | 0.300 |
Why?
|
| Forced Expiratory Volume | 3 | 2014 | 122 | 0.280 |
Why?
|
| Papilloma | 2 | 2020 | 22 | 0.280 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 144 | 0.270 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 865 | 0.270 |
Why?
|
| Prospective Studies | 7 | 2023 | 4213 | 0.250 |
Why?
|
| Quality of Life | 5 | 2024 | 1585 | 0.250 |
Why?
|
| Outpatients | 1 | 2024 | 94 | 0.230 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2023 | 17 | 0.230 |
Why?
|
| Evidence-Based Medicine | 3 | 2021 | 429 | 0.230 |
Why?
|
| Prevalence | 2 | 2023 | 1239 | 0.230 |
Why?
|
| Chest Tubes | 2 | 2020 | 23 | 0.220 |
Why?
|
| Pulmonary Ventilation | 2 | 2014 | 32 | 0.210 |
Why?
|
| Patient Selection | 3 | 2021 | 685 | 0.210 |
Why?
|
| Hypertrophy | 2 | 2013 | 62 | 0.210 |
Why?
|
| United States | 6 | 2022 | 6672 | 0.210 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2021 | 8 | 0.210 |
Why?
|
| Exhalation | 2 | 2014 | 7 | 0.210 |
Why?
|
| Receptor, Endothelin A | 1 | 2021 | 22 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2015 | 1204 | 0.200 |
Why?
|
| Inpatients | 1 | 2024 | 297 | 0.190 |
Why?
|
| Precision Medicine | 2 | 2016 | 395 | 0.190 |
Why?
|
| Educational Measurement | 2 | 2014 | 225 | 0.190 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 3640 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 1464 | 0.180 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2019 | 6 | 0.180 |
Why?
|
| Feasibility Studies | 2 | 2023 | 751 | 0.180 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2019 | 7 | 0.180 |
Why?
|
| Decision Making | 3 | 2021 | 642 | 0.180 |
Why?
|
| Clinical Protocols | 1 | 2020 | 156 | 0.180 |
Why?
|
| Contraindications | 1 | 2019 | 72 | 0.180 |
Why?
|
| Cryotherapy | 1 | 2019 | 29 | 0.180 |
Why?
|
| Societies, Medical | 2 | 2020 | 572 | 0.180 |
Why?
|
| Steroids | 1 | 2020 | 177 | 0.180 |
Why?
|
| Adult | 9 | 2020 | 25648 | 0.180 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 46 | 0.180 |
Why?
|
| Infection Control | 1 | 2020 | 115 | 0.170 |
Why?
|
| Hypotension | 1 | 2019 | 70 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 263 | 0.170 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 203 | 0.170 |
Why?
|
| Hospitals | 1 | 2022 | 294 | 0.170 |
Why?
|
| Mortality | 1 | 2019 | 149 | 0.170 |
Why?
|
| Consensus | 1 | 2020 | 335 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2022 | 7993 | 0.160 |
Why?
|
| Intraoperative Complications | 1 | 2019 | 185 | 0.160 |
Why?
|
| Radiosurgery | 1 | 2021 | 272 | 0.160 |
Why?
|
| Needles | 1 | 2017 | 35 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2020 | 839 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 6509 | 0.150 |
Why?
|
| Computer-Assisted Instruction | 1 | 2017 | 43 | 0.150 |
Why?
|
| Respiratory Tract Fistula | 1 | 2017 | 9 | 0.150 |
Why?
|
| Disease Progression | 3 | 2017 | 1531 | 0.150 |
Why?
|
| Pleural Diseases | 1 | 2017 | 13 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 999 | 0.150 |
Why?
|
| Muscle, Smooth | 2 | 2016 | 354 | 0.150 |
Why?
|
| Time | 1 | 2016 | 77 | 0.140 |
Why?
|
| Oscillometry | 2 | 2013 | 25 | 0.140 |
Why?
|
| Length of Stay | 1 | 2020 | 702 | 0.140 |
Why?
|
| Shock | 1 | 2016 | 42 | 0.140 |
Why?
|
| Electromagnetic Fields | 1 | 2016 | 26 | 0.140 |
Why?
|
| Spirometry | 3 | 2013 | 66 | 0.140 |
Why?
|
| Metals | 1 | 2016 | 90 | 0.140 |
Why?
|
| Logistic Models | 1 | 2019 | 1186 | 0.140 |
Why?
|
| Cryosurgery | 1 | 2016 | 41 | 0.140 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 159 | 0.140 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 1673 | 0.130 |
Why?
|
| Electromagnetic Phenomena | 3 | 2021 | 18 | 0.130 |
Why?
|
| Fractals | 1 | 2015 | 42 | 0.130 |
Why?
|
| Hot Temperature | 1 | 2016 | 206 | 0.130 |
Why?
|
| Prognosis | 4 | 2021 | 3679 | 0.130 |
Why?
|
| Curriculum | 2 | 2017 | 539 | 0.130 |
Why?
|
| Pulmonary Atelectasis | 2 | 2011 | 18 | 0.130 |
Why?
|
| Brachytherapy | 1 | 2016 | 119 | 0.130 |
Why?
|
| Bronchoconstriction | 1 | 2014 | 55 | 0.130 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 1169 | 0.130 |
Why?
|
| Hypoxia | 1 | 2019 | 641 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 457 | 0.120 |
Why?
|
| Educational Status | 1 | 2014 | 188 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 552 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1036 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 508 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 130 | 0.110 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 1801 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2013 | 162 | 0.110 |
Why?
|
| Airway Extubation | 1 | 2012 | 13 | 0.110 |
Why?
|
| Ventilator Weaning | 1 | 2012 | 24 | 0.110 |
Why?
|
| Risk Factors | 2 | 2020 | 5417 | 0.110 |
Why?
|
| Genetic Testing | 1 | 2016 | 535 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2013 | 219 | 0.100 |
Why?
|
| Photosensitizing Agents | 2 | 2023 | 48 | 0.100 |
Why?
|
| Nurse's Role | 1 | 2011 | 12 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2013 | 169 | 0.100 |
Why?
|
| Observer Variation | 1 | 2013 | 602 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 567 | 0.100 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2011 | 16 | 0.100 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 469 | 0.100 |
Why?
|
| Recurrence | 2 | 2010 | 1139 | 0.090 |
Why?
|
| Bronchomalacia | 1 | 2010 | 1 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2023 | 2767 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 369 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2011 | 217 | 0.090 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2009 | 37 | 0.090 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 98 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2014 | 1078 | 0.090 |
Why?
|
| Light Coagulation | 1 | 2009 | 6 | 0.090 |
Why?
|
| Bronchitis | 1 | 2009 | 7 | 0.090 |
Why?
|
| Tracheitis | 1 | 2009 | 3 | 0.090 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2009 | 8 | 0.090 |
Why?
|
| Equipment Design | 1 | 2010 | 406 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2009 | 135 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2009 | 278 | 0.080 |
Why?
|
| Polychondritis, Relapsing | 1 | 2008 | 5 | 0.080 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2009 | 58 | 0.080 |
Why?
|
| Tracheotomy | 1 | 2008 | 18 | 0.080 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2007 | 4 | 0.080 |
Why?
|
| Vital Capacity | 1 | 2007 | 64 | 0.080 |
Why?
|
| Infant | 1 | 2014 | 3046 | 0.080 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2007 | 15 | 0.080 |
Why?
|
| Hemoptysis | 1 | 2007 | 24 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 579 | 0.070 |
Why?
|
| Spinal Neoplasms | 1 | 2007 | 50 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 49 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1830 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2705 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2006 | 33 | 0.070 |
Why?
|
| Mediastinum | 2 | 2021 | 46 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1565 | 0.070 |
Why?
|
| Syndrome | 1 | 2006 | 446 | 0.070 |
Why?
|
| Software | 1 | 2009 | 654 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 813 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2007 | 219 | 0.060 |
Why?
|
| Dihematoporphyrin Ether | 1 | 2023 | 4 | 0.060 |
Why?
|
| Granuloma | 1 | 2023 | 65 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2023 | 114 | 0.050 |
Why?
|
| Light | 1 | 2023 | 289 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1538 | 0.050 |
Why?
|
| Ipilimumab | 1 | 2021 | 58 | 0.050 |
Why?
|
| SEER Program | 1 | 2022 | 190 | 0.050 |
Why?
|
| Calibration | 1 | 2021 | 99 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 1376 | 0.050 |
Why?
|
| Obesity | 1 | 2007 | 963 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 2501 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 48 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 2261 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 410 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 5210 | 0.040 |
Why?
|
| Air | 1 | 2017 | 62 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 2438 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 309 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 5976 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1054 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 971 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1753 | 0.030 |
Why?
|
| Vibration | 1 | 2011 | 49 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 720 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 26582 | 0.020 |
Why?
|
| Knowledge | 1 | 2010 | 29 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 293 | 0.020 |
Why?
|
| Debridement | 1 | 2009 | 56 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 372 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1749 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2009 | 117 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 280 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2007 | 281 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 407 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 3968 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 311 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2007 | 930 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3362 | 0.010 |
Why?
|